Companies Dominating the Next-Generation Biomanufacturing Landscape
- Sartorius AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Regeneron Pharmaceuticals, Inc.
- GEA Group Aktiengesellschaft
- PBS Biotech Inc.
- Applikon Biotechnology BV
- Danaher Corporation
- Merck KGaA
- Shanghai Bailum Biotechnology Co., Ltd.
- Solaris Biotechnology Srl.
- ZETA GmbH
Browse Key Market Insights with Data Illustration:
In the News
- June 2023 - Extending their cooperative agreement that started with upstream bioprocessing analytics, Waterways Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing. Bioprocess engineers will have access to more thorough analytical data for downstream batch and continuous manufacturing through software and hardware integrations between the SartoriusTM Resolute® BioSMBTM multi-column chromatography platform and the WatersTM PATROLTM UltraPerformance Liquid Chromatography (UPLCTM) Process Analysis System. This will improve yields while lowering waste and biomanufacturing costs.
- August 2023 - Regeneron Pharmaceuticals, Inc. announced that it has reached a collaborative agreement with the Biomedical Advanced Research & Development Authority (BARDA) to facilitate the clinical development, clinical manufacturing, and regulatory licensure process of a novel COVID-19 monoclonal antibody therapy aimed at preventing SARS-CoV-2 infection. The deal is a component of the U.S. Department of Health and Human Services (HHS) "Project NextGen," which aims to develop a pipeline of novel COVID-19 vaccines and treatments.
